Part D open enrollment for 2018 has begun and will continue through December 7th. During this time, if you’re a Medicare enrollee and do not have a plan, then you should pick one. If you already have a plan, you should shop around because plans change! Premiums and deductibles go up or down, drugs get dropped from formularies, new plans come into the marketplace and others exit. Our website, MedicareDrugPlans.com, has a variety of basic plan information to help you in your search, such as premiums, deductibles, coverage gaps, and whether the plan premium is waived if you have a lower income. The most useful thing about MedicareDrugPlans.com is that you can read ratings and reviews about the plans by people who actually know because they use them. That means that if you were using Part D during 2017, you have the opportunity to help others and rate your plan.
MedicareDrugPlans.com is a supplemental information site to maximize your research when choosing your plan. However, the best place to finalize and select your plan is the on the government’s website. There, you will enter in your zip code, Medicare info, names of the medications you take, and find out which plans cover those medications.
As usual, current plan ratings and reviews don’t paint a pretty picture of Medicare Part D.
PLEASE: I strongly advise, (more…)
Tagged with: government assistance, healthcare, Medicare, medicare plans, Part D, ratings, reviews
PharmacyChecker.com is proud of the work we do to advocate for your access to affordable medication, and we welcome you, your sister, and your sister’s husband’s cousin to join us!
The greed of pharmaceutical companies has become overbearing: not only their price gouging, but rampant public relations and lobbying campaigns attempt to muzzle the majority of Americans who demand lower drug prices.
Tagged with: Advocacy, Drug Prices, Lower Drug Prices
Pfizer wants to sell Viagra to you without you having to go to your doctor to get a prescription first. Sorry Yanks—this only applies to our friends that live in the United Kingdom, but this is absolutely of interest to us Americans because of Pfizer’s history with misleading public information campaigns surrounding sildenafil citrate (the generic name for Viagra). Those campaigns scare people from lower-cost Viagra available online.
But why? The per pill cost of Viagra today is as high as $75/100 mg pill. That’s $450 for just six pills! If you look hard, you can find it for just under $60 at your local U.S. pharmacy. In Canada, it’s as low as about $11; New Zealand about $9. Compare Viagra prices available online from pharmacies that do require your prescription.
Now that you understand Pfizer’s financial interest in trying to make sure Americans buy locally, let’s talk about prescription requirements and Viagra.
Pfizer has spent considerable sums of money fighting online sales of Viagra in the name of protecting patients from getting counterfeit drugs and has warned consumers not to buy it without a prescription. That media narrative scares men from buying lower-cost, genuine Viagra online. This includes from online pharmacies that do require a valid prescription. I’ve told this Viagra truth before.
But where does Pfizer really stand on the prescription requirement? (more…)
Tagged with: no prescription, Pfizer, United Kingdom, Viagra
There is profound frustration and anger reverberating throughout the diabetic community due to the skyrocketing prices of insulin in the United States. Pharmaceutical companies like Novo Nordisk, Eli Lilly and Sanofi are charging out-of-reach prices for insulin medications necessary for diabetics’ survival.
On September 9th, 2017, over forty people gathered outside of Eli Lilly headquarters in Indianapolis to make a statement on behalf of American citizens living with diabetes and, in actuality, all Americans who face the highest drug prices in the world.
Tagged with: #insulin4all, Big Pharma, diabetes, Drug Prices, Eli Lilly, Insulin, Novo Nordisk
At the beginning of this year, Prescription Justice, the non-profit organization I founded, released an analysis showing that about 45 million Americans did not fill a prescription in 2016 due to cost. We derived that figure by looking at 2016 survey data by the Commonwealth Fund, a research organization dedicated to healthcare policy. Its international survey showed that 18% of the adult population in the U.S. did not fill a prescription due to cost. The UK’s rate was nine times lower at 2%.
Last week, I came across new information that showed about six million Americans of Medicare age were included among the 45 million. A new cross-sectional study of Commonwealth Fund international survey data from 2014 shows the percentage of older adults, 55 and up, that do not take medication because of drug prices. People in 11 high-income countries—22,532 overall—were asked if they had gone without prescribed medications in the past year because of cost.
In the U.S., 16.8% of 1593 people said yes.
For those 65 and older the percentage was 12%.
U.S. Census data from July of 2016 shows that there are about 48 million Americans 65 and older.
That means 5.8 million Americans, 65 and older, forgo taking their meds due to cost.
For international comparison: the percentage of older people skipping medications due to prices in the UK was 3.1%. In France, it was only 1.6%.
Sadly, it was quite high in Canada and Australia: 8.3%, and 6.8%, respectively.
The academic, medical term for such medication skipping because of prices is called cost-related nonadherence (CRNA). It’s a serious public health issue, one in which Americans end up getting sicker, going to the emergency room, or dead solely because they can’t pay for medications. As we move into the season when Medicare beneficiaries pick Part D plans, we’ll continue to look at how our oldest citizens are affected by high drug prices. But it’s clear that Medicare pharmacy benefits are falling far short of what is needed. While price should not block ANYONE from essential medications, the fact that so many millions of our oldest citizens who need their prescribed meds the most are forced to go without is disgusting.
Tagged with: Commonwealth Fund, CRNA, older americans
This week, Merck’s CEO, Kenneth Frazier, resigned from President Donald Trump’s American Manufacturing Council in protest over the president’s initial response to the violence in Charlottesville, VA. White supremacist groups came together to protest the removal of a statue of Robert E. Lee, who headed the Confederate Army, and counter-protesters clashed this past Saturday. During the events, a self-affiliating white supremacist drove a car into a crowd of counter-protesters, killing one person and injuring 19. The president condemned the violence but made it seem as if both sides, white supremacists and counter-protesters, were equally to blame, which is wrong. Mr. Frazier believed that President Trump should have forcefully and clearly criticized white supremacists.
I strongly agree with and applaud Mr. Frazier’s action. However, I felt compelled to write about this issue because President Trump mocked Mr. Frazier on Twitter about high drug prices. He wrote: “Now that Ken Frazier of Merck Pharma has resigned from President’s Manufacturing Council, he will have more time to LOWER RIPOFF DRUG PRICES!”
Mr. Frazier, the son of a hardworking janitor, worked his way up to his current position. He is also African American. For obvious and good reasons, he took a stand. But Mr. Frazier is also CEO of a Big Pharma company and not interested in lower drug prices.
President Trump is the one who needs to act, and President Trump is the one who can lower drug prices.
Trump supported legalizing importation of lower cost medications during his presidential campaign. It was one of his few positions that has wide, bi-partisan public support. He has the executive authority, via the Secretary of Health and Human Services, to expressly permit personal drug importation now.
Now is the time to use that authority.
Tagged with: Big Pharma, Drug Prices, Kenneth Frazier, Merck, President Trump, Robert E. Lee